Prosperity Consulting Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$453K Buy
+4,382
New +$391K 0.02% 412
2025
Q2
Sell
-3,145
Closed -$213K 458
2025
Q1
$213K Buy
+3,145
New +$188K 0.02% 435
2024
Q4
Sell
-3,193
Closed -$201K 467
2024
Q3
$201K Sell
3,193
-341
-10% -$19.9K 0.02% 448
2024
Q2
$209K Sell
3,534
-797
-18% -$49.9K 0.03% 292
2024
Q1
$345K Buy
4,331
+638
+17% +$48.7K 0.04% 259
2023
Q4
$292K Buy
3,693
+479
+15% +$34.1K 0.1% 160
2023
Q3
$224K Buy
+3,214
New +$228K 0.1% 131
2022
Q1
Sell
-1,877
Closed -$204K 96
2021
Q4
$204K Buy
+1,877
New +$173K 0.15% 94

Other funds holding CVS

Prosperity Consulting Group's CVS Position: Q2 2026 in Review

Prosperity Consulting Group opened a new position in CVS Health (CVS) in Q2 2026: 4,382 shares worth $453K. The stake represents 0.02% of the portfolio and ranks #412 among its holdings. This is a return to the name: Prosperity Consulting Group previously reported a position in CVS as recently as Q1 2025.

Prosperity Consulting Group first reported a position in CVS in Q4 2021 and has held it in 8 quarters since. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Prosperity Consulting Group held 4,382 shares of CVS Health worth $453K as of Q2 2026.
  • CVS Health was a new Prosperity Consulting Group position in Q2 2026.
  • CVS Health made up 0.02% of Prosperity Consulting Group's portfolio in Q2 2026, its #412 holding.
  • Prosperity Consulting Group first reported a position in CVS Health in Q4 2021 and has held it in 8 quarters since.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Prosperity Consulting Group's 13F filing for Q2 2026, filed 13 Aug 2026.